Dr. Bernard Le Foll

Dr. Bernard Le Foll joined the Waypoint senior leadership team in February 2022. Dr. Le Foll is a clinician-scientist specializing in drug addiction. He is the Chair of Addiction Psychiatry at the University of Toronto and is a Professor in the departments of Psychiatry, Family and Community Medicine, Pharmacology and Toxicology and Psychiatry.

Dr. Le Foll is also a Senior Scientist at the Centre for Addiction and Mental Health (CAMH) and Vice-President of Research and Academics and Chief Scientific Officer at Waypoint. He has practiced in the area of Addiction Medicine at CAMH since 2006. His multi-disciplinary research approach seeks to better understand the neurobiology of addiction and develop novel therapeutic strategies.

He obtained his PhD in Pharmacology at University of Paris Sud in France and has performed post-doctoral training in behavioral pharmacology and brain imaging within the intra-mural program of the National Institutes of Health. He has received more than 100 grants.

Dr. Le Foll has published more than 300 peer-reviewed scientific articles. He has been an advisor for multiple agencies, has developed clinical guidelines, been involved in policy and been invited to speak at the Senate and House of Commons on addiction related issues.